A patient with T1N0 glottic laryngeal carcinoma is scheduled…
A patient with T1N0 glottic laryngeal carcinoma is scheduled to receive definitive radiation therapy. During treatment planning, the radiation oncologist prescribes a very small treatment field that includes only the larynx with minimal surrounding tissue, which is notably smaller than the fields typically used for other head and neck cancers. What is the primary rationale for using such a limited treatment field for early-stage glottic cancers?